Teiimo establishes a new category of intelligent garments that capture vital parameters. The garment records data, analyzes it and makes the information accessible to the patient, his doctors and care takers. The company’s focus is on healthcare and medical applications. Teiimo’s technology allows for soft and comfortable integration of sensors into base layers such that the garment becomes a comfortable sensing device.
STENTiT is focused on the development of regenerative endovascular implants. The company's technology will be bioresorbable and capable of activating the body's naturally healing response to restore diseased arteries from the inside-out.
AppMed's APPY platform is a software solution that allows patients and their healthcare providers to optimize pharmacological treatment strategies for patients with ADHD. The solution computes and visualizes pharmacokinetic profiles of various drug combinations that maximize drug treatments in combination with routinely submitted patient-specific data to optimize patient care.
Liva Healthcare are digitizing personal healthcare. The company's digital health platform provides users with personalized coaching and tailored lifestyle plans. Currently the company offers digital programs for weight management and diabetes prevention.
Milan Krojicek, Vice President R&D & Manufacturing H2 Global Group
Electrical Capacitance Tomography (ECT) uses electric fields to measure the permittivity of an object. When applied to a medical device, ECT can be used to identify cancers due to the increased permittivity seen as a result of cellular disarray that cancer causes. Zedsen is using this approach to develop a portable, non-invasive, and affordable solution to bring early cancer detection into the community clinic and general practitioners offices.
Icarus Medical is harnessing 3D printing to bring patients personalized knee braces that more effectively reduce pain and improve function and movement activity. Using a 3D scan captured via a smartphone application, Icarus Medical produces custom braces in just two weeks to get patients comfortably ambulating.
Endospan's Nexus is a minimally invasive solution designed to simplify aortic arch repair. The Nexus system consists of a modular arch stent graft, ascending stent graft, and a distal extension that is placed using a proprietary delivery system that provides stable anchoring and atraumatic sealing across a range of aortic pathologies.
Silent brain infarcts occur in nearly all patients who undergo transcatheter aortic valve replacement. These stealth incidents lead to cognitive decline and significantly increase a patient's risk of future stroke. To combat this, Protembis are developing the ProtEmbo Cerebral Protection System. This catheter-based solution is deployed during leftsided heart procedures to deflect embolic material away from cerebrovascular circulation.
binx health's point-of-care diagnostic solution, binx io, is an FDA-cleared, CLIA-waved platform intended to enhance community health outcomes through access to affordable and rapid testing results. The company's system utilizes ultra-rapid polymerase chain reaction (PCR) amplification to obtain results in approximately 30 minutes. binx's diagnostic tests are initially focused on providing men and women with rapid access to results for sexually transmitted infections (STIs).
The Shape Sensing Company is seeking to take minimally invasive surgery into the next generation. Shape sensing technology utilizes fiber optic sensors to detect the shape and location of medical devices (e.g., catheters, endoscopes) within the body. The company's technology will minimize the complexity associated with traditional instrument navigating and tracking methods, such as fluoroscopy and ultrasound, while providing clinicians with comprehensive instrument tracking data.
Ryan DeBoer, Vice President of Strategic Partnerships The Shape Sensing Company
Neurostech exists at the crossroads of the medtech & pharmaceutical industry. The company is investigating innovative medtech and pharma products for the treatment of neurological conditions. Neurostech specializes in utilizing its knowledge of cerebrospinal fluid (CSF) dynamics and bioengineering to deliver drugs across the blood-brain barrier. The initial application for this platform drug delivery solution will be as a preventative treatment for Alzheimer's disease.
Rafael Permuy Martínez, Founder Partner & Chief Business Officer Neuroscience Innovative Technologies (Neurostech)
ABCDx is focused on the discovery, clinical validation and commercialization of a Software as Medical Device (SaMD) platform to evaluate cerebrovascular disorders. The BRAINCheck solution captures and analyzes brain biomarkers from a single drop of blood to triage stroke and traumatic brain injury (TBI) patients via a smartphone application.
earAccess strives to improve access to high-quality, cost-effective hearing aids. The company is on a social mission to improve access to hearing care, particularly in underserved communities and developing countries. The company offers a portfolio of hearing aids that are designed to endure drastic climates, from extreme cold and heat, to dust and humidity.
CathVision's solution is a proprietary low-noise EP system that helps guide electrophysiologists during cardiac ablation procedures. The ECGenius System enhances signal quality, helping physicians identify, diagnose, and treat complex cardiac arrhythmias. CathVision's ECGenius is paired with CARDIALYTICS, a suite of proprietary AI-powered analytical tools that are intended to provide automated analyses of electrograms to support physicians and improve outcomes.
Magneto Thrombectomy Solutions are evaluating innovative, catheter-based solutions to transform the way thrombi (clots) are retrieved. The company's technology is based on the understanding of the electric properties of clots, which allow the Magneto catheter to function as a magnet for clots.
Benny Dilmoney, CEO Magneto Thrombectomy Solutions
Choice have developed small, implantable, wirelessly controlled valves as a contraceptive. Placed in a short, outpatient procedure, without the need for surgery, Choice valves open or close the fallopian tubes. The Choice system does not contain active electronics, batteries, or active chemical components.
CloverLife is addressing some of the largest challenges in the increasing population of patients suffering from heart valve disease. The company is developing an innovative mechanical heart valve that will offer improved durability compared to existing valves, without the need for anticoagulant therapy.
Alphyn Biologics is developing therapies to treat common skin diseases. At the core of this approach is the company's Multi-Target Therapeutics (MTT) AB-101 platform. The AB-101 platform is currently being investigated for the treatment of atopic dermatitis.
Opsin Biotherapeutics is a joint venture that combines the expertise of Nanoscope Technologies with DesignPlex Biomedical to create unique products and alternatives to opioids and spinal cord stimulation for the treatment of chronic pain. Opsin's therapy specifically targets and activates the neurons that block pain through the delivery of light sensitive proteins that are activated via a low power LED light.
Melodi Health offers surgical solutions for the tens of thousands of women undergoing breast reconstruction each year. The company is developing an absorbable scaffold that is intended to provide support to soft tissue and reduce post-operative infections via the elution of antibiotics.
Senseye is building a platform to support patients in managing their mental health. The Senseye mobile application uses computer vision to capture metrics from the eye. Data collected is analyzed by the company's machine learning algorithm to provide objective diagnosis and monitoring of mental health. The application is initially being developed for the diagnosis of post-traumatic stress disorder (PTSD).
Vigor Medical is developing life-saving technologies and products for the treatment of chest trauma. Vigor's self-fixation sealing device, C-Lant, prevents the collapse of the heart and lung in cases of severe chest trauma. The C-Land device uses a proprietary self-fixation mechanism to hermetically seal any wound surface, provide immediate hemostasis, and create an accessible drainage shaft for the exchange of catheters.
Avi Hirsch, Director of Business Development Vigor Medical
Capri-Medical seeks to change the way neuromodulation therapies are delivered. The company's injectable neurostimulation device will make this type of therapy more accessible for a number of indications. The technology is currently being evaluated for the treatment of chronic peripheral nerve pain.
Angel Valve Vienna (AVVie) is developing a novel, minimally invasive implant to address mitral valve regurgitation. The Mitral Butterfly implant features a unique, physiological design to facilitate the reconstruction of the mitral valve in cases of mitral valve prolapse. The device can be placed directly onto the diseased valve's leaflet in a one-step transcatheter procedure.
Annaida Technologies vision is to transform the way microscopic life is measured, analyzed, and understood. The company's MRS (magnetic resonance spectroscopy) device is a non-invasive technology that looks at metabolic activity at the cellular level, providing new insights for the life sciences industry. Annaida's lead product, EmbryoSpin, detects and quantifies biomarkers to support Assisted Reproductive Therapies and improve embryo selection. The technology addresses many of the challenges and risks associated with current screening methodologies.
BrightHeart is developing an artificial intelligence (AI) software company focused on improving the detection of congenital heart defects from fetal ultrasounds. Leveraging a proprietary database of 20,000 ultrasound exams, BrightHeart's AI and expertise in fetal ultrasound cardiac imaging helps improve caregivers' detection of complex heart defects in utero, during an ultrasound exam, when early interventions could correct or improve a child's chance of survival.
ViCentra's Kaleido device is a new insulin delivery system designed to give patients with diabetes freedom and peace of mind, with a focus on device customization. The system combines a handset with a micro-pulse delivery system that can be customized to be worn how patients to use choose.
Caresytnax's vendor-neutral, enterprise-grade digital surgery platform is designed to help multiple stakeholders improve care delivery. Using artificial intelligence and big data, the platform is enabling healthcare providers to improve the quality of care inside and outside of the operating room.
ReGelTec, Inc. is a clinical stage medical device company developing the next generation of interventional spinal implants for chronic lower back pain due to degenerative disc disease. Hydrafil is a Injectable hydrogel for Degenerative Disc Disease the procedure has a very short recovery time 1-2 hrs post injection with early clinical results showing significant improvement in back pain and ODI scores.
NuVision Biotherapies is a biotechnology company seeking to develop cost-effective and high-quality regenerative therapies for ophthalmology. The company's lead product, Omnigen, is a natural wound dressing and grafting material used to aid the natural healing process of the eye in cases of soft tissue damage.
Digital-Surgery-as-a-Service (DSaaS) combining the power of a new microsurgery platform with a system of big data analytics and machine learning to provide advanced surgical assistance in performing delicate or intricate procedures.
MY01 has developed a device to continuously monitor and manage acute compartment syndrome in muscles. The MY01 device is a sterile, single-use device that quickly measures muscle pressure following orthopedic surgery for trauma.
Caira® Surgical is pioneering the development of radar-based surgical tracking, rapid landmark registration, and other leading-edge technologies to revolutionize usability, economics, and access to advanced surgical navigation and robotics for orthopedic surgery. The company's first product is Radar Surgical Navigation™ for Total Knee Replacement. Caira's proprietary sub-millimeter-accurate Radar Surgical Tracking for navigated and robotic procedures eliminates line-of-sight interference, invasive bone pins, and multiple incisions inherent in existing surgical tracking systems. Our technology enables a simple workflow and significantly reduces operative time, complexity, and cost. We develop solutions that improve patient outcomes and eliminate adoption barriers to improve access to cutting-edge technology for surgeons, patients, outpatient surgery centers, and hospitals worldwide.
Non-invasive ventilation (NIV) is a first line therapy in patients presenting with respiratory insufficiency or failure, as well as in patients coming off mechanical ventilation. There are many challenges associated with the NIV masks that reduce patient QoL and can lead to poor outcomes. ReddyPort is developing products to address these challenges and improve NIV success via an innovative elbow that features a self-sealing valve that provides access to the patient's mouth to facilitate cleaning and moisturizing the patient's mouth without disrupting therapy.
Branden Rosenhan, Co-Founder and Board of Directors ReddyPort
Picard Medical is the parent company of SynCardia, a developer of mechanical heart replacement technologies for patients suffering from end-stage heart failure. SynCardia develops and commercializes an FDA-approved temporary Total Artificial Heart (TAH). The implantable TAH system is designed to assume all the functions of a failing human heart in transplant-eligible patients at risk of imminent death from biventricular failure.
Daniel Teo, Executive Director Picard Medical (SynCardia Systems)
Tens of millions of men worldwide experience symptoms of benign prostate hyperplasia (BPH). The Omega device by ProArc Medical is a minimally invasive, non-surgical procedure to restore urinary function and treat lower urinary tract symptoms (LUTS) caused by an enlarged prostate.
AccurKardia is an ECG-led diagnostics company. We are unlocking the value of the ECG signal towards broad diagnostics coverage and disease management in cardiology and beyond. This holds the key to improving clinical outcomes and saving lives at a planetary scale.
AccurKardia's first product, AccurECG is an FDA cleared, cloud-based, and device agnostic software for fully automated ECG interpretation and arrhythmia diagnosis for up to 13 arrhythmias. It is intended to assist cardiac monitoring companies in the analysis of ECGs recorded from holters, event recorders and cardiac telemetry devices.
The Company completed Cohort 3 of Mayo Clinic Platform_Accelerate in July 2023.
Nerve repair technology is long due for an advancement beyond current interventional options. Tulavi Therapeutics is working to provide a higher standard of care when it comes to nerve care. The company is engineering simple, OR-based solutions to proactively prevent nerve pain and promote nerve regeneration, with an initial focus on treating the nerves of limbs.
Sinaptica Therapeutics is a clinical-stage company that is developing a personalized closed-loop neuromodulation therapy for Alzheimer’s Disease. The company’s SinaptiStim System represents a totally new approach to treating AD by enhancing neuroplasticity via noninvasive neurostimulation of key brain networks involved in memory. The therapy has been clinically demonstrated to slow the progression of cognitive decline and functional decline in patients with mild-to-moderate Alzheimer's disease.
The eyemate system from Implandata Ophthalmic Products is an eye pressure measurement system for patients with glaucoma. The digital health solution enables improved therapeutic guidance and protection of eyesight for glaucoma patients. The system consists of an implantable microsensor that communicates with hand-held devices. eyemate provides real time information regarding the effectiveness and therapy and disease status.
Max Ostermeier, CEO & Founder Implandata Ophthalmic Products
Long-term, non-thermal resolution of atrial fibrillation. AtriAN Medical is developing an innovative solution for the treatment of AF that utilizes micro-Pulsed Electric Field (mPEF). This non-thermal approach targets hyperactive cell structures on the outside of the heart and disrupts the errent electrical signals that are responsible for AF, while sparing healthy tissue.
NOxy Health Products is a healthcare company driven to developing innovative medicines that harness the natural restorative capabilities of nitric oxide (NO) to heal chronic wounds. Due to various factors, the body can lack the natural ability to produce and deliver sufficient NO. The company is investigating topical means to deliver NO exogenously to improve oxygen and nutrient flow to wounds, promote healthy inflammation, and stimulate the development of new microvessels and tissue.
Indigo is providing an answer to the need for accurate and accessible chronic disease management solutions. The company is using nanophotonics in its continuous multi-metabolite monitoring (CMM) sensor. This small sensor measures the absorption of light in the interstitial fluid to quantify concentrations of multiple metabolites without the use of enzymes or fluorophores.
Founded in 2015, I-VASC is focused on bringing its Empty Vein Ablation (EVA) technology for the treatment of varicose veins to the global market. The Velex system is a minimally invasive, nonthermal and non-tumescent device for sclerotherapy. Featuring an innovative 3 balloon design, the Velex system removes blood from the diseased vessel to improve the effectiveness of the injected chemically ablative drug.
Cristiano Fontana, Board Member- Head of Business Development I-VASC
Keratoconus is a progressive eye disease of the cornea the leads to distorted vision and poor quality. RECORNEA's GROSSO implant restores the physiological curvature of the cornea and halts progression of the disease.
Emiliano Lepore, Co-founder, CEO and Chairman RECORNEA
Insight Surgery provides digital planning and point-of-care surgical guides for all surgical disciplines. The company offers an extensive range of products and services intended to improve patient outcomes and optimize operational expenses.
Robopedics' Awake is a robotic orthopedic solution specifically for stroke victims. Awake has been designed specifically for the rehabilitation of hemiplegia and hemiparesis due to stroke. The device is an alternative to exoskeletons, being more accessible and ergonomic means to help stroke patients return home, improve their quality of life, and ultimately be able to walk on their own.
everSens specializes in the design, development, and manufacture of solutions for the analysis of human respiration. The company's Evernoa Base measures the fraction of exhaled nitric oxide (FeNO) present in the human breath to noninvasively detect exhaled biomarkers to disease inflammatory respiratory diseases, such as asthma.
CYTO365 is looking to change the way infusion therapy is delivered. The company's RondelO stopcock manifold effectively prevents accidental, and potentially life-threatening, drug mixing in patients. The device provides an extra-layer of security that clearly indicates which drug is active to healthcare providers while also offering an integrated flushing that separates drugs from mixing down the line.
3dthinks is developing solutions for individuals with disabilities that limit how they can function in the world. The company's proficiencies in additive manufacturing (3D printing) and digital technologies are creating new solutions for patients with disabilities that limit their independence. From innovative solutions using smartphone apps and AR to improve communication to a mounted communication device that gives wheelchair-bound individuals the freedom to drive without assistance – 3dthinks seeks to improve lives with affordable innovations.
At IQ Endoscopes, we are creating pioneering, sustainable endoscopy technologies for the early diagnosis of diseases, helping to create a world where everyone has access to sustainable sterile endoscopy. Our Single Use Gastroscope is currently under regulatory review and this will be quickly followed by regulatory submissions for our single use colonoscope and sigmoidoscope in 2024. This compelling platform will enable IQ Endoscopes to offer healthcare professionals the most comprehensive range of single use technology to address the Gastro Intestinal market, whilst also ensuring key sustainability requirements are surpassed. With commercial activities set to begin in 2025, the organization is at a very exciting stage.
Rethink Medical is focused on developing novel medical devices, based on nursing experience. Its T-Control catheter, through an in-built fluid controlling valve, addresses currently unmet needs related to conventional catheters. It improves patients' quality of life, prevents infections and enhances the work efficiency of the healthcare staff, generating savings to the healthcare system too.
Szilvia Endrenyi, CEO & Co-founder Rethink Medical
PreciHealth is committed towards enabling individuals to easily and safely self-administer medication and collect diagnostic blood samples from the comfort of their home. With a focus on the use of innovative micromechanics and microfluidics, the company is developing a portfolio of auto injectors (i.e., drug delivery) and blood collection devices.
Vivasure's PerQseal closure device is touted as the first fully bioabsorbable, sutureless and entirely synthetic option to close large-bore arteriotomies that result from percutaneous transcatheter procedures like transcatheter aortic valve replacement (TAVR) and endovascular abdominal aortic aneurysm repair (EVAR).
Alesi Surgical's Ultravision system utilizes the process of electrostatic precipitation to eliminate surgical smoke that accumulates during laparoscopic surgery. The device maintains a continuously clear visual field without the need for CO2. The Ultravision system has been evaluated in a range of procedures, from gastrointestinal, gynecological, urological and in robotic-assisted laparoscopic procedures.
Echopoint Medical is developing a family of optical-fiber based sensors which integrate into microcatheters to guide and improve outcomes during interventional cardiology procedures. The company's iKor platform translates ultrasonic signals to measure blood pressure and flow to more accurately assess, diagnose and treat patients with coronary artery disease and coronary microvascular dysfunction.
Adtec Healthcare are specialists in energy-based technologies. Cold plasma, which is electron dense, charged, ionized gas, that is safe to the touch has many different applications in healthcare. Adtech is commercializing a cold plasma solution, SteriPlas, for infection control applications. The use of cold plasma has been clinically proven to effectively treat biofilms, wounds, surgical site infections, and bacterial skin conditions as an alternative to antibiotics.
TendoMend's Dynamic Tendon Grip surgical device that replaces the traditional, time-consuming techniques currently used for the repair of ruptured tendons. The Dynamic Tendon Grip consists of a low-profile implant and a dedicated applicator that creates a grip akin to the original tendon profile while simultaneously improving suture connection strength. With an initial focus on hand tendon laceration, TendoMend plans to modify their platform technology for use in the repair of Achilles, bicep, quadricep & patella tendon ruptures.
Pacertool develops PaCRTool, a solution to improve cardiac resynchronization therapy (CRT) in heart failure patients. PaCRTool provides healthcare professionals with quantifiable evidence to determine when CRT is effectively applied to heart failure patients and ensure synergy from biventricular pacing. The system also functions as a simple electrophysiology system for AV node ablations and PES.
UpSurgeOn's mission is to fill the gap between theory and practice in surgery via psychomotor skill augmentation. To achieve this, the company has developed a mixed reality digital platform that combines smartphone applications, augmented & virtual reality, and physical simulators to improve surgical training. UpSurgeOn is currently focused on the development of surgical simulator courses for neurosurgical skills.
Bloomlife is focused on building out its commercialization efforts for its first product, a smart pregnancy wearable that automatically detects and tracks contractions which expectant moms can visualize on their smartphone. With their innovative technology, Bloomlife allows the expectant mom to better understand her body and gain peace of mind throughout the third trimester.
Nirtek has created a patented device that utilizes near infrared light to evaluate intracoronary plaque. When the light is directed at unstable plaques an autofluorescence signal is detected by the device to indicate which diseased vessels require interventional therapy. The NIRAF device fits into the current coronary angiogram workflow while providing clinicians with new insights into unstable plaque that could progress to heart attack.
Conavi Medical is a commercial-stage medical device company. Its flagship product is the Novasight Hybrid system, a unique coronary imaging system that combines co-registered ultrasound (IVUS) and optics (OCT). Conavi is looking to further expand its base of clinical evidence for the 510(k)-cleared Novasight System and ready the system for broad market adoption.
TAE Life Sciences, a subsidiary of TAE Technologies, is leveraging accelerator-based neutron beam technology for Boron Neutron Capture Therapy (BNCT) to bring promising treatment potential for head and neck, glioblastoma multiforme (GBM) and other cancers that are difficult to treat with traditional methods.
Opto Biosystems seeks to transform the way patients with neurological disorders are treated. The company is focused on the emerging field of bioelectronics to develop wirelessly powered sensors to diagnose and treat serious neurological conditions from epilepsy to brain cancer.
MedLumics is developing a real-time, optical coherence tomography (OCT) guided ablation catheter. The PulseView system combines radiofrequency ablation and pulsed-field ablation to treat atrial fibrillation. The technology can directly assess lesion creation, providing physicians with confidence regarding the continuity and transmurality of the lesion and improving treatment durability.
OncoHost aims to help providers and patients understand a patient's unique response to cancer therapies. The PROphet platform combines bioinformatics, system biology, proteomic pattern recognition, and machine learning to provide clinicians with actional clinical insights to optimize patient therapy.
Mirai Medical ePORE therapy is a unique precision therapy platform that targets and destroy tumor tissue without harming surrounding healthy tissue. The minimally invasive technology delivers pulsed electrical fields that create pores in the cell membrane of tumor cells, catalyzing cellular death. Mirai's technology has been developed for external (skin) and internal (endoscopic) tumor treatment.
Pristine Surgical makes a high definition single-use visualization system for minimally invasive surgery and delivers its visualization devices in complete single-use kits. The devices utilize a low-cost image processing unit which also serves as a portal to cloud-based software supporting the entire surgical episode.
Open Stent Solution are pioneering a novel approach for the treatment of mitral valve regurgitation. The company is developing a unique transcatheter heart valve that is supported by a ribbon-shaped stent structure which overcomes the challenges associated with conventional cylindrical stents. OSS seeks to overcome the anatomical constraints that make transcatheter mitral valve delivery and implantation challenging with its unique technology.
Rob Surgical is developing a surgical robotic system for minimally invasive surgery. The Bitrack System is an open robotic system designed to support a large scope of abdominal and pelvic surgical procedures. The system's unique robotic column architecture provides multi-quadrant surgical access to enable four-quadrant anatomical access and complete patient accessibility.
Sonic Incytes' Velacur is a portable, handheld ultrasound that integrates machine learning to enhance image guidance, resulting in a confident assessment of liver health in all body types. Scans using the Velacur system can be performed in the physician office in approximately 5 minutes, producing real-time measurements of liver stiffness and attenuation.
Coronary artery disease (CAD) is society's biggest killer. When not proactively managed, the disease requires costly surgical interventions that can carry post-surgical risks to patients. AMT Medical has developed a suture-less medical device that makes open-heart surgery less complex for interventionists and safer for patients. To-date, the company's patented solution has been successfully utilized in 10 patients in a first-in-human trial.
SmartCardia's 7L Patch is a wearable 7-lead electrocardiogram (ECG) patch for cardiology and remote patient monitoring. The wearable enables real-time monitoring and detection of cardiac arrhythmias and is enhanced by the addition of machine learning software to enhance the detection of arrhythmic events and patient deterioration.
Scalpel's digital platform has been designed to address key challenges and improve the operation of the operation room. Using artificial intelligence (AI) and noninvasive sensors, Scalpel helps hospitals and providers manage inventory, optimize instrument trays, and provide detailed peri-operative data analytics.
Happitech has developed a CE-marked, smartphone-based method for effective remote monitoring of patients. The company's core competencies in artificial intelligence (AI) integration and photoplethysmography (PPG) enable effective and accurate measurement of heart rate and atrial fibrillation.
Ostoform's mission is to improve skin health and quality of life in people living with an ostomy. The company's Ostoform device prevents and protects the seal adhesive from the output of the ileostomy leaking onto the patient's skin, keeping skin healthy and giving the patient confidence, while simultaneously directing output into the ostomy pouch.
Wander Health's digital platform is designed to connect travelers with English-speaking healthcare providers across the globe. The company's digital medical concierge platform facilitates healthcare utilization in foreign countries for primary and urgent care needs.
Approxima is an early-stage medtech startup developing a minimally invasive solution for tricuspid valve repair. The device is based on a right ventricular reshaping approach to treat patients with tricuspid regurgitation.
DIP235 believes that physics can be used to fight cancer by impacting biology and immunology as a whole, thereby drastically improving treatment. The company is developing a unique technology for targeted, physics-based cancer therapy. The technology utilizes electromagnetic waves and pulsed microwaves in a vacuum chamber to create plasmas that are further stimulated by powerful pulsed electromagnetic fields (PEMF).
SamanTree Medical's Histolog Scanner is a digital microscopy scanner for high-resolution imaging of the surface of fresh tissue. The device utilizes novel, ultra-fast confocal microscopy technology to enable rapid histological assessment in the operating room or pathology laboratory.
Quibim is using artificial intelligence to unlock new insights from medical images. The company's SaaS platform harnesses AI techniques to obtain digital biomarkers and new data from CT, MRI, and PET images. The platform is a "one-stop-shop" that handles, integrates, stores and processes multi-omics data with imaging that enhances patient care and optimizes drug development programs.
The Levita Magnetic Surgical System is an innovative technological platform that utilizes magnetic retraction designed to grasp and retract tissue and organs in laparoscopic cholecystectomy procedures to facilitate access and visualization of the surgical site. Levita Magnetic has implemented this technology into a robotic platform to assist in the performance of laparoscopic surgeries.
Vektor Medical's vMAP system helps identify the sources of stable and unstable arrhythmia using accessible, noninvasive electrocardiogram (ECG) data. Clinicians upload ECG data into the vMAP system, which then interprets and visualizes the data in 3D to identify sources of arrhythmia inside and outside of the heart. The FDA-cleared vMAP system is capable of creating a "heat map" of the heart in < 3 minutes to support or improve ablation treatment planning.
THERYQ specializes in the design and production of linear accelerators for radiotherapy. The company's FLASH technology is intended to increase the effectiveness of radiotherapy, by taking the conventional radiotherapy process requiring multiple treatment sessions and weeks of irradiation and condensing it into a single procedure performed in milliseconds. The result of this high energy radiotherapy is a reduction in the side effects while simultaneously increasing treatment efficacy.
XEOS is focused on improving outcomes in surgical oncology by leveraging the power of molecular imaging in the operating room. The company’sAURA 10 specimen PET-CT imagerprovides surgeons with an immediate 3-dimensional visualization of the resected tissue specimen at the point of surgery. This information helps the surgeon ensure that a complete resection is obtained.
Neuromod Devices is a medtech company focused on utilizing bimodal neuromodulation to treat chronic neurological conditions. The lead application for the company's technology is the Lenire device for the treatment of tinnitus. The Lenire solution is combines synchronized stimulation of the auditory nerve and nerves of the tongue to soothe and relieve tinnitus.
Hy2Care's vision is to support patients in the fight against osteoarthritis. The company's lead product, CartRevive, is a hydrogel implant composed of dextran and hyaluronic acid conjugates that form a resorbable scaffold when injected. The hydrogel enables natural restoration of tissue defects by creating an environment conducive to cell regrowth that proceeds towards the restoration of smooth hyaline cartilage.
Body Vision's fusion imaging platform enables pulmonologists, for the first time, to use all the existing imaging modalities together, in real time, without changing or affecting the procedural flow. The Body Vision System, together with a unique delivery device, enables the physician to plan the procedure, navigate to challenging locations and localize the lesion during biopsy. This complete solution will facilitate early-stage diagnosis of lung cancer and, in addition, will pave the way for minimally invasive transcatheter therapeutics.
Shuttle Catheter's technology addresses an unmet need in minimally invasive procedures. The company is developing an innovative catheter solution that enables minimally invasive procedures for crossing through severe arterial stenosis, plugging arterial ruptures, and preventing gastric reflux complications.
Mihalis Boutaris, Co-Founder & CEO IntraCross Catheter
CardiaCare is developing a closed-loop neuromodulation device for the monitoring and prevention of atrial fibrillation. The wearable device utilizes medical grade artificial intelligence predict and deliver personalized, non-invasive electrical stimulation to the median Vagus nerve to reduce the occurrence of premature atrial contractions that are a precursor to episodes of atrial fibrillation.
Acorai is developing a non-invasive monitoring solution to measure pulmonary artery pressure. The handheld device utilizes a unique combination of acoustic, electrocardiographic, pressure, seismic and visual sensors to collect robust data to be analyzed using a machine learning engine to evaluate heart failure progression. The company's solution is an alternative to the current standard procedure, which involves right heart catheterization performed in a catheterization lab to evaluate heart functionality.
Cardiac Success is committed to providing a new solution for the millions of patients who continue to suffer and deteriorate from heart failure with reduced ejection fraction. The V-sling is a transcatheter ventricular repair device that is designed to treat left ventricular dysfunction by repositioning the papillary muscles and restoring the conical shape of the left ventricle for improved cardiac function.
InnoTech Precision Medicine's mission is to bring high-performance diagnostics into the point-of-care. The company's diagnostic technology is based on the multi-modal and simultaneous detection of multiple classes of disease biomarkers from a single test to support accurate and early disease detection. The InnoTech Recognize test is a minimally equipped device that uses synthetic molecular biosensors to target multiple types of biomarkers that would traditionally require separate RT-PCR and antibody/antigen tests to detect multiple diseases.
Roya Khosravi-Far, President & CEO Innotech Precision Medical
A Cleveland Clinic spinoff company commercializing the Intra-Operative Positioning System (IOPS™) technology — an innovative, non-x-ray based 3D GPS-like surgical navigation technology that improves endovascular procedure outcomes and reduces radiation exposure.
Tympany Medical is developing a next-gen endoscope for sinus surgery - Solascope. The device features sterile panoramic, lens-cleaning technology intended to reduce the number of scopes and time required to perform endoscopic procedures. The company is focused on circular manufacturing utilizing reusable and recyclable components that reduce environmental impact.
Colorectal cancer is highly preventable when polyps are identified during routine screening procedures, however, over 20% of polyps are missed due to visual limitations of colonoscopes. MiWendo is developing a novel solution that attaches to conventional colonoscopes to increase field-of-view and differentiate between malignant and benign polyps. The accessory uses non-ionizing electromagnetic energy to sense and differentiate polyps, without changing the current clinical practice for colonoscopy.
EP Solutions is improving clinical outcomes in cardiac resynchronization therapy cases through the use of noninvasive cardiac mapping technology. The company's Amycard 01C is an electrophysiology workstation that records body surface electrograms to create optimized 3D heart models that merge ECG data with anatomical data obtained from medical imaging. EP Solutions' technology helps physicians accurately place CRT leads during implantation and optimize devices during follow-up visits.
Sedivention aims to transform the way obesity is treated. The company is developing a gastric balloon equipped with cryoablative technology to freeze the gastric nerves inside of the stomach in a short procedure similar to gastroscopy. The technology is being evaluated as a means of turning off the "hunger nerves" to help patients realize improvements in weight management and diabetes control.
PanTher Therapeutics is a privately-held oncology company with a proprietary treatment platform for solid tumors. PanTher's Sagittari platform merges minimally invasive, surgically implant devices with chemotherapeutic agents to deliver targeted drug to the tumoral area. The technology bypasses the limitations associated with traditional chemotherapy routes of administration, while maximizing local effectiveness. The Sagitarri platform is initially being evaluated for the treatment of pancreatic cancer.
Intelligent Implants is working on the future of electrotherapeutic orthopedic devices. The company's mission is to develop a portfolio of smart, cloud-connected implants that can accelerate, control, and remotely monitor bone growth. Intelligent Implant's lead product is the SmartFuse System, which combines the company's proprietary electrotherapeutic technology platform with an intervertebral spacer to improve outcomes in lumbar spinal fusion procedures.
Canary Medical is giving a "voice" to implantable medical devices through the use of proprietary integrative sensor technology. The company's canturio platform creates new opportunities to improve patient outcomes and lower the cost of care through the generation of relevant data from implanted medical devices. Canary's lead product, the canturio te, is a modified tibial extension for use with Zimmer Biomet's Persona prosthetic knee joint that captures patient activity data that helps manage prosthetic knee post-surgical recovery.
Kent Imaging is using multispectral oxygenation imaging to enhance the care of chronic wounds. The company's lead product, SnapshotNIR, is a portable tool that utilizes near-infrared (NIR), reflectance-based technology to measure tissue oxygen saturation in superficial tissue. The information collected by the device improves the data available to care providers when making medical decisions that positively impact patient outcomes in wound care.
ScreenPoint Medical's Transpara is an artificial intelligence (AI) solution to enhance early breast cancer detection and diagnosis. At the core of Transpara is FusionAI, a proprietary platform that merges pathology, clinical imaging, deep learning techniques, and X-ray physics. The software fits into existing workflows, providing radiologists with decision support that improve clinical accuracy, optimize workflow, and reduce workload.
Nano4Imaging has developed an magnetic resonance (MR) compatible guidewire to transfer select cardiovascular procedures from the cathlab to the MRI suite. Initially focused on developing their solutions for congenital heart diseases, the company plans to expand their technology into interventional procedures, such as angioplasty.
Aqua Heart is developing an over-the-wire, single shot ablation solution for the treatment of atrial fibrillation (AFib). The technology combines radiofrequency and balloon elements to bring familiar thermal ablation via a new technique that is a safe and fast way to perform pulmonary vein isolation.
Fluid Biomed is a VC-backed pre-clinical medical device start-up that has developed the world’s first bio-resorbable stent to cure brain aneurysms. Our innovative polymer technology allows physicians the versatility of treating a wider variety of aneurysms more safely and efficiently. Backed by years of laboratory research, a strong IP and tech transfer position, and contract manufacturing partners, the company is opening a $10M Series A round to launch human clinical trials.
GreenBone Ortho develops and commercializes patented, innovative, wood-derived bone regenerative implants for bone reconstruction. The company's technology transforms wood into a mixture of hydroxyapatite (HA) and beta-tricalcium phosphate (TCP) to produce a porous structure similar to normal healthy bone. GreenBone's b. Bone implant possesses a nanocrystalline structure that allows vascularization and the necessary exchange of biological fluids to support bone regeneration.
RevBio is using tetranite, a unique organic compound, as the base for its platform of bone adhesive biomaterials. The company's proprietary biomaterial is capable of multi-surface bonding, rapidly reaching mechanical stability, performing well in wet fields, and biodegrading at a controlled rate. RevBio's tetranite is under investigation for use in dental, cranial, trauma, spine, and animal health markets, with additional expansion opportunities identified.
AnchorValve is developing an innovative solution that addresses the limitations of current solutions for transcatheter mitral valve replacement (TMVR) and tricuspid valve replacement (TTVR). The company is developing a two-step device that is delivered transeptally, which consists of docking platform anchors that firmly anchor the valve to minimize para-device leakage and a valved stent. Unlike conventional devices, which are placed deep inside the left ventricle, AnchorValve's solution is positioned between the left atrium and ventricle - allowing the valve leaflets to move freely, with reduced need for lifetime anticoagulation therapy.
WISE's competitive advantage is built on a proprietary technology, Supersonic Technology, that allows for the insertion of electronic microcircuits in biocompatible silicones. WISE's lead product, the WISE Cortical Strip, is a single-use medical device for intraoperative neurophysiological monitoring during brain tumor and epilepsy surgeries. In addition, the company is developing the Heron lead, an expandable percutaneous paddle lead for spinal cord stimulation.
Xenter is focused on developing new wireless medical device and giital technologies for interventional cardiology, radiology, and neurointerventional radiology. At the core of the company's technology is Physical Intelligence, which gives healthcare providers real-time in-vivo data to solve acute issues and produce durable results.
Orixha's LunoLIVE platform uses the lungs as a thermal bio-exchanger to continuously and precisely adjust a patient's blood and body temperature. The technology produces a hypothermic effect and protect the brain, heart and kidneys from the inflammatory cytokine storm that occurs in cardiac arrest patients.
Tada Medical's ReLink Care is a CE-marked breakaway connector for intravenous (IV) lines. The device is designed to reduce complications and costs due to accidental disconnections that occur during home and hospital infusion therapy.
Katarina Hedbeck, CEO & Co-Founder Tada Medical AB
Biomedical Bonding aims to introduce the next generation of solutions for fracture and bone restoration. The company is developing a medical adhesive and composite platform technology for hard and soft tissue indications. Biomedical Bonding's lead product, Bonevolent Adhfix, is a biomaterial solution that overcomes the challenges of current therapies for bone fractures by adapting to any bone shape without the need for metal plates.
Visit website.elina Mikaelson has an M.Sc. from Uppsala University in business, economics, and law and she has extensive experience and excellent track record regarding management, business development, sales and profit improvements from previous positions as Head of Business for various companies and business units within the Adlibris group. Most recently she holds an executive position within explorative digital development and innovation at The Agency for digital Government.isit
Evelina Mikaelson, CEO Biomedical Bonding AB
Kenota Health is developing a point-of-care diagnostic solution to simplify allergy testing. The company's lead product is a rapid system that utilizes a small blood sample to test patient's allergic sensitizations in the clinic in under 30 minutes.
Vitestro is developing an autonomous platform for drawing blood. The company's device combines AI-based, ultrasound-guided 3D reconstruction with robotic needle insertion to insure accurate and secure blood collection.
Sensome is developing an innovative remote and non-invasive monitoring system for implantable medical devices allowing the characterization of the tissue surrounding the device. The company's sensing technology combines impedance-based micro-sensors with machine learning algorithms to identify biological tissues upon contact. The lead application for Sensome's technology is the Clotild connected guidewire for the treatment of ischemic stroke.
NeuraLace Medical are the developer's of Axon Therapy, an FDA-cleared solution for the management of chronic pain. Axon Therapy uses noninvasive, magnetic pulse technology to treat chronic nerve pain in patients recovery from injury or surgical procedures.
Healium medical is focused on advancing atrial fibrillation treatment with an innovative, no-contact guided ablation technology that allows simultaneous tissue ablation and lesion monitoring. The company's Echomplish platform features miniature transcatheter ultrasound technology to deliver precise ultrasonic energy for safe and rapid lesion formation.
FibroBiologics is a regenerative medicine company developing an innovative solution for chronic disease treatment using fibroblast cells. The company's pipeline currently consists of multiple fibroblast cell-based therapies for degenerative disc disease, multiple sclerosis, wound healing and other chronic diseases.
Pete O'Heeron, Chairman, CEO, & Founder FibroBiologics
Otivio is a medical device company based in Oslo, Norway. Our vision is to stimulate active self care and treatment through simple and easy to use home treatment devices and services. We plan to launch our product, FlowOx, for treatment of Multiple Sclerosis Spasticity Symptoms in Scandinavia in first quarter 2024.
Arsenal Medical develops purpose-built biomaterials to solve challenging and underserved medical problems. Our lead products target neurovascular and trauma conditions providing control of blood flow to tumors and hemorrhage.
MexBrain is developing a novel technology to remove free metals from the blood. The company's technology combines dialysis and nanotechnology to restore metal homeostasis in patients with Acute Kidney Injury and Wilson's disease.
Ceretrieve is developing CathTrap, a uniquely designed aspiration catheter that offers improved handling, enhanced clot aspiration, and improved retention of clots during removal. CathTrap features a proprietary large bore funnel and closure tip to securely remove clots in ischemic stroke cases.
Augmedit develops augmented reality tools to empower physicians and inform patients. Lumi is a platform of technologies intended to create 3D visualizations of medical images into interactive AR models for pre- and peri-operative use. Currently the company is focused on applying its core technology to neurosurgery, with plans to take their technology beyond the head in the future.
e-Scopics is democratizing ultrasound imaging for all healthcare professionals. The company manufactures a digital transducer and a connected software APP to provides quantitative imaging for several medical conditions. The image formation process is no longer hardware based but rather a SaaS running on a cell phone, a Tablet or the Cloud, with AI based algorithms for quantitative diagnosis.
SharpView Ophthalmology is committed to developing medical technologies in the field of ocular implants for macular disorders. The company's lead product, EyeMax Mono, uses innovative lens technology for patients with dry AMD and cataracts. EyeMaxMono makes it possible for patients to use the functioning areas of the macula that are not as severely affected by disease to improve their vision.
Hypervision Surgical is developing an AI-driven intraoperative imaging system for wide-field tissue differentiation to identify normal tissue, nerves, blood vessels and tumors in real time. The technology is non-invasive, non-contact and does not require the use of exogenous contrast agent.
Michael Ebner, CEO & Co-Founder Hypervision Surgical
OrthoSon's minimally invasive, motion-restoring treatment is being developed as an alternative to spinal fusion for the treatment of degenerated discs. The treatment, which was spun out of the University of Oxford, involves the injection of sonosensitive particles into degenerated disc vertebrae and then activated with ultrasound to perform controlled nucleotomy. Once the degenerated nucleus has been fragmented, a liquid nucleus replacement is injected into the cavity and cured - providing patients with a well integrated prosthetic. The entire procedure replaces a degenerated nucleus pulposus through a single 1.5mm annulus puncture.
Haermonics has developed a novel drainage system to prevent complications in postoperative open-heart surgery patients. The Haermonics Laebroides system continuously flushes and cleans the pericardial space - preventing complications such as unevacuated blood and clots that occur around the heart.
InVera Medical is developing a catheter-based therapy for chronic venous disease. The device uses non-thermal energy to disrupts the inner vessel lining, resulting in natural scarring and vessel closure that diverts blood flow away from diseased vessels.
SpinaFX Medical is committed to bridging the therapeutic gap (conservative vs. surgery) in the treatment of back and leg pain caused by a contained herniated disc. The company is pioneering a minimally invasive, image-guided treatment that injects a mixture of oxygen and ozone gas to reduce herniated disc volume. Animal studies and mathematical modeling have shown that a reduction in disc volume can lead to reduced pressure, thereby relieving nerve root compression and herniated disc-related pain.
Positrigo is developing a functional positron emission tomography (PET) system with a small footprint at a fraction of the cost of current PET scanners. The company's NeuroLF system is an ultra-compact, dedicated PET system for the brain.
Trukera Medical is building a portfolio of products to address unmet needs in eye care for patients and providers. The company's ScoutPro osmolarity system is a handheld osmolarity testing device for the detection of toxic hyperosmolarity, a condition which damages corneal cells and drives refractive instability.
Joseph McGinley, Founder & CEO McGinley Orthopedics
Agile Devices is a medical device development company dedicated to the invention and realization of innovative steerable and deflectable catheter technologies that reduce procedure time, cost, and risk. With a focus on interventional radiology, cardiology and neuroradiology, Agile Devices' Angler Microcatheter features novel coaxial deflection technologies to make interventions cost-effective, faster, and safer.
Medinbox has developed a real-time, smart collaboration solution for use in the operating room and cathlab. The technology is designed to be easily operated and seamlessly integrate into the existing medical environment. Medinbox can utilize up to 16 imaging inputs to open up the OR for remote proctoring, support, and training & education. The company's solution is intended to simplify recording, live streaming, and collaboration.
CorNeat Vision has developed a proprietary platform for developing nondegradable, biomimetic biomaterials to treat diseases. The company's EverMAtrix material is a 100% synthetic, nondegradable porous material that mimics the micro-structure of the extracellular matric (ECM). CorNeat's technology has been applied to products for dental and ophthalmic surgery.
Solenic Medical is developing a non-invasive medical device that utilizes alternating magnetic fields to eradicate biofilms that form on implants. The company's platform uses external magnetic coils to destroy infective biofilms on the surface of knee and hi replacement implants, as well as plates and rods for trauma related procedures. Solenic's solution is being developed to replace the expensive and risky two-step revision surgery, which is the current standard of care for chronic infections on medical implants.
Field Medical is developing a next-generation pulsed field ablation (PFA) solution for the treatment of cardiac arrhythmia. The company is building a purpose-built system that incorporates PFA, contact force sensing, and electromagnetic localization mapping capabilities to address the limitations of first-generation PFA technologies and deliver more efficacious therapy.
Vascular Perfusion Solutions specializes in the development of technologies to enhance the preservation of organs. The VP.S ENCORE device is designed to extend the viability of organs for transplantation beyond the current standard of care. The device consists of a single-use disposable unit that operates with a non-blood, nutrient-rich solution. VPS is currently focused on developing the device for use in heart transplantation, with plans to modify the device for the preservation of other organs, ex vivo therapies, and organ banking.
Rafael J. Veraza, CEO & President Vascular Perfusion Solutions
Cyclic Variations in Altitude Conditioning (CVAC) is a is an effort-free method for physical conditioning for individuals of all ages and activity levels to improve fitness. The CVAC process applies precisely composed rhythm-based changes to pressure, temperature and density of air to create waves of tension and relaxation. These changes simulate breathing, muscle contraction, and blow flow changes consistent with circuit, interval and strength training.
NovaResp has developed a patented software compatible with any positive airway pressure (PAP) machine to dramatically improve comfort and adherence to therapy for obstructive sleep apnea (OSA) patients. The company's platform software uses artificial intelligence and machine learning during PAP therapy to predict and prevent episodes of apnea before they would occur. As a result, personalized therapy can be delivered via PAP machines at lower, more comfortable air pressure levels.
Hamed Hanafi, President & CEO NovaResp Technologies
Nurami Medical is a developer of soft tissue repair technologies that leverage the company's expertise in brain physiology, nanofibers, and biomaterials. Nurami's technology utilizes a combination of electrospun nanofiber scaffolds and advanced bioactive materials. The company's flagship product, ArtiFascia, is a synthetic dural graft intended to facilitate the healing of the dura after cranial neurosurgery by creating an effective barrier that prevents harmful CSF leaks in dura repairs.
EASEE is Precisis' neurostimulation device that can act in two modes - excitatory and inhibitory. The duality of the device allows its to be used for the treatment of many cerebral diseases, including epilepsy, depression, and cognitive disfunctions caused by stroke. Precisis is currently developing a close-loop system for their EASEE technology, which will allow the device to record brain activity and respond with targeted stimulation.
Gyder Surgical's Gyder Hip System is a non-invasive, pin-less navigation solution for total hip replacement. The system is an open platform that can be used with a surgeon's preferred implant system, reduces radiation exposure by not requiring CT or X-ray imaging, and seamlessly integrates into existing workflows due to the system's simple set-up and quick calibration.
Having been spun-out from Oxford University, Oxford Endovascular is developing OxiFlow, a next-generation flow-diverter to reduce the risk of complications and ruptures in patients with intracranial aneurysms.
ThinkSono is democratizing access to ultrasound devices. The company's ThinkSono AI platform uses artificial intelligence to guide and empower training with ultrasound at the point-of-care – allowing non-specialists to rapidly learn how to perform ultrasound examinations. Beyond ultrasound training, the company is developing AutoDVT, an AI-enabled solution that enables healthcare professionals to perform point-of-care scans for Deep Vein Thrombosis using a handheld ultrasound transducer and mobile phone.
StemMedical's mission is to change the paradigm for stem cell therapy. The company's platform is versatile and enables the production of affordable mesenchymal stem cells for clinical and commercial use. The platform isolates a small number of adipose tissue-derived stem/stromal cells and then produces and expands a desirable concentration of MSCs from the initial sample. StemMedical is currently focused on two strategic segments: the cosmetic surgery market and inflammatory conditions.
Josef Christensen, Chief Business Development Officer StemMedical
QV Bioelectronics is developing innovative electrotherapy devices for the treatment of certain types of brain tumors. The company's technology utilizes Electric Field Therapy to emit specific frequencies of electric fields that disrupt cancer cell growth cycles. The company's first device, GRACE, is an implanted device that delivers Electric Field Therapy to the tumor resection margins in patients with glioblastoma multiforme.
Christopher Bullock, CEO & Co-Founder QV Bioelectronics
Image Navigation creates solutions to improve dental care. The company's flagship product, Image Guided Implantology (IGI), utilizes CT scans and presurgical planning to guide dental implant placement. The IGI system is intended to reduce procedure time, support the surgeon, and minimize postoperative morbidity. Image Navigation also offers DentSim - an augmented reality dental simulation to help dental students hone their skills.
ZiO Health has developed a proprietary, miniaturized technology that brings lab-quality testing to the point-of-care for various single-point and continuous monitoring applications. The technology utilizes artificial intelligence for applications in therapeutic drug monitoring and precision dosing to improve patient drug outcomes. Beyond drug monitoring, the company is evaluating its technology for home-based molecular level testing and consulting and other partnership-based solutions.
Osteal Therapeutics is a musculoskeletal therapeutics company developing solutions for the treatment of orthopedic infections. The company's lead product, VT-X7, is a drug-device combination that utilizes high concentrations of vancomycin and tobramycin, in conjunction with a drug delivery system, to irrigate infected joint spaces as a result of periprosthetic joint infection in joint replacement patients.
Innoventric is developing a reliable, easy-to-use percutaneous solution for treating tricuspid regurgitation. The company's Trillium™ device uses cross-caval anchoring, a unique multi-valve design, and fits a wide range of anatomies without the risks of migration and leaks. The Trillium™ has completed a 20-patient FIH study in Germany, Belgium, and Spain, showing excellent clinical results, with a < 10-minute transcatheter procedure.
Retia makes advanced hemodynamic monitors using the patented Multi-Beat Analysis MBA™ algorithm to guide care for high-risk surgical and ICU patients. Using the data from our monitor, clinicians implement proven protocols that reduce acute kidney injuries, myocardial injuries and other costly complications.
FluidAI is developing smart monitoring solutions to detect anastomotic postoperative complications early. The company's plug-and-play technology integrates seamlessly with existing peritoneal drains and catheters to provide physicians with active patient monitoring of leakage-related surgical complications.
inHeart's technology generates a 3D map of the patient's heart from medical images to provide physicians with a highly detailed anatomical map, including structural substrate for both ventricles and atria.
Bionic vision for those who have lost their sight. Bioelectronics and brain machine interface technology company specialized in neuromodulation application whose mission is to create a world of bionic vision for those who have lost their sight, enabling them to regain partial visual perception and greater autonomy.
Alio's SmartPatch is a discrete patch that continuously monitors and tracks vitals, including O2 saturation, temperature, blood pressure, and more. The company's remote patient monitoring platform is being developed as an alternative to one-metric devices and consumer-grade sensors (i.e. fitness trackers) that do not capture clinical-grade data.
Newronika is developing AlphaDBS, a closed-loop deep brain neuromodulation system for the management of symptoms due to Parkinson's disease. AlphaDBS interprets the bioelectrical neuronal activity (local field potentials, LFPs) in the brain areas where stimulation is delivered and accordingly adapts moment-by-moment the stimulation to follow patient’s clinical condition.
Novuson’s patented DTU technology will represent the first substantive innovation in over 25 years for targeting vessel sealing / dividing, and hemostasis (bleeding control) in surgical and trauma applications.
TibaRay is developing a next-generation radiation therapy technology, called PHASER, to deliver radiation treatment with unprecedented accuracy and exquisite shaping by ultrafast imaging. The PHASER system verifies tumor and organ positioning and "freezes" motion as treatment is delivered.
Locate Bio is working to solve some of the most complex degenerative and infectious diseases that affect the muscular skeletal system. Locate utilises Programmed Drug Release to re-align the bioavailability of existing drugs with the underlying biological need. This bio-optimisation step has demonstrated break through improvements in performance in preclinical testing.
Locate Bio’s lead product, LDGraft, is entering human clinical studies next year, for the treatment of chronic lower back pain caused by degenerative disc disease. CognitOss Gel is in developed to overcome bacterial biofilm infections around non-viable tissue and orthopaedic implants.
CAPS Medical is developing a solution to treat a wide range of solid tumors using Non-thermal Atmospheric Plasma (NTAP). This minimally invasive procedure selectively destroys cancer cells without damaging the surrounding healthy tissue.